XSHE300796
Market cap489mUSD
Jan 10, Last price
9.93CNY
1D
-1.78%
1Q
-9.81%
IPO
10.87%
Name
Bsm Chemical Co Ltd
Chart & Performance
Profile
Shaoxing BSM Chemical Co., Ltd. engages in the research and development, and procurement of chemical intermediates of pendimethalin worldwide. It offers mononitroxylene isomers and dimethylaniline series reduction products, such as 4-nitro-o-xylene, N-(1-ethylpropyl) -3,4-dimethylaniline, etc. The company was founded in 2003 and is based in Hangzhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 699,191 -8.97% | 768,072 44.91% | |||||||
Cost of revenue | 540,888 | 541,892 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 158,303 | 226,180 | |||||||
NOPBT Margin | 22.64% | 29.45% | |||||||
Operating Taxes | 18,548 | 25,917 | |||||||
Tax Rate | 11.72% | 11.46% | |||||||
NOPAT | 139,755 | 200,263 | |||||||
Net income | 88,411 -42.17% | 152,885 171.10% | |||||||
Dividends | (34,020) | (8,599) | |||||||
Dividend yield | 0.57% | 0.22% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 220,091 | 166,629 | |||||||
Long-term debt | 308,816 | 111,502 | |||||||
Deferred revenue | 28,868 | 28,889 | |||||||
Other long-term liabilities | 72,368 | 28,889 | |||||||
Net debt | (215,637) | (510,500) | |||||||
Cash flow | |||||||||
Cash from operating activities | 113,447 | 186,519 | |||||||
CAPEX | |||||||||
Cash from investing activities | (445,744) | ||||||||
Cash from financing activities | 218,035 | 461,284 | |||||||
FCF | 95,241 | (45,110) | |||||||
Balance | |||||||||
Cash | 661,508 | 617,588 | |||||||
Long term investments | 83,035 | 171,043 | |||||||
Excess cash | 709,584 | 750,227 | |||||||
Stockholders' equity | 879,487 | 647,398 | |||||||
Invested Capital | 1,592,656 | 1,301,738 | |||||||
ROIC | 9.66% | 18.29% | |||||||
ROCE | 6.77% | 11.78% | |||||||
EV | |||||||||
Common stock shares outstanding | 368,378 | 348,345 | |||||||
Price | 16.10 43.47% | 11.22 62.16% | |||||||
Market cap | 5,930,892 51.72% | 3,909,204 85.02% | |||||||
EV | 5,744,162 | 3,423,166 | |||||||
EBITDA | 213,099 | 274,513 | |||||||
EV/EBITDA | 26.96 | 12.47 | |||||||
Interest | 7,835 | 9,317 | |||||||
Interest/NOPBT | 4.95% | 4.12% |